Inhaled nitric oxide: Therapeutic applications in cardiothoracic surgery

Annals of Thoracic Surgery

Volumn 61, Issue 6, 1996, Pages 1856-1864

  Fullerton, David A ^a,b   McIntyre Jr , Robert C ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC GMP; GLYCERYL TRINITRATE; HEPARIN; METHEMOGLOBIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROGEN DIOXIDE; NITROPRUSSIDE SODIUM; PROSTACYCLIN; PROSTAGLANDIN E1; PROTAMINE SULFATE; VASODILATOR AGENT;

ADULT RESPIRATORY DISTRESS SYNDROME; CARDIOPULMONARY BYPASS; CONGENITAL HEART MALFORMATION; EXTRACORPOREAL OXYGENATION; HUMAN; HYPOXEMIA; HYPOXIC LUNG VASOCONSTRICTION; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; LUNG INJURY; LUNG VASCULAR RESISTANCE; MITRAL VALVE REPLACEMENT; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SURGICAL PATIENT; THORAX SURGERY;

EID: 0029992772     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/0003-4975(96)00046-X     Document Type: Review

References (56)

1. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
2. Fullerton DA, Hahn AR, Banerjee A, Harken AH. Pulmonary vascular smooth muscle relaxation by cGMP- versus cAMP-mediated mechanisms. J Surg Res 1994;57:259-63.
3. Fullerton DA, Agrafojo J, McIntyre RC Jr. Pulmonary vascular smooth muscle relaxation by cAMP-mediated pathways. J Surg Res 1996;61:444-8.
4. McIntyre RC Jr, Harken AH, Fullerton DA. Mechanisms of pulmonary vasomotor function in normal and injured lung. Surgery 1994;115:273-5.
5. Clutton-Brock J. Two cases of poisoning by contamination of nitrous oxide with the higher oxides of nitrogen during anaesthesia. Br J Anaesth 1967;39:388-92.
6. Stavert DM, Lehnert BE. Nitric oxide and nitrogen dioxide as inducers of acute pulmonary injury when inhaled at relatively high concentrations for brief periods. Inhalation Toxicol 1990;2:53-67.
7. Greenbaum R, Day J, Hargreaves MD, et al. Effects of higher oxides of nitrogen on the anesthetized dog. Br J Anaesth 1967;39:393-404.
8. Oda H, Kusumoto S, Nakajima T. Nitrosyl-hemoglobin formation in the blood of animals exposed to nitric oxide. Arch Environ Health 1975;30:453-6.
9. Hugod C. Effect of exposure to 43 ppm nitric oxide and 3.6 ppm nitrogen dioxide on rabbit lung. Int Arch Occup Environ Health 1979;42:159-67.
10. Rossaint R, Falke K, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993;328:399-405.
11. Bocchi EA, Bacal F, Auler JOC, de Carvalho MJ, Bellotti G, Pileggi F. Inhaled nitric oxide leading to pulmonary edema in stable severe heart failure. Am J Cardiol 1994;74:70-4.
12. Centers for Disease Control. NIOSH recommendations for occupational safety and health standards 1988. MMWR 1988;37(Suppl 7):1-29.
13. Price D. Methemogolinemia. In: Goldfrank LR, Flowenbaen NE, Lwein NA, Weisman RS, Howland MA, Hoffman RS, eds. Toxicologic emergencies. 5th ed. Norwalk, CT: Appleton & Lange, 1994:1169-78.
14. Adatia I, Lillehei C, Arnold JH, et al. Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantation. Ann Thorac Surg 1994;57:1311-8.
15. Williams TJ, Salamonsen RF, Snell G, Daye D, Esmore DS. Preliminary experience with inhaled nitric oxide for acute pulmonary hypertension after heart transplantation. J Heart Lung Transplant 1995;14:419-23.
16. McIntyre RC Jr, Haenel JB, Moore FA, Read RR, Burch J, Moore EE. Cardiopulmonary effects of permissive hypercapnia (PHC) in adult respiratory distress syndrome. J Trauma 1994;37:433-8.
17. Kinsella JP, Neish SR, Shaffer E, Abman SH. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340:819-20.
18. Roberts JD, Polaner DM, Lang P, Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340:818-9.
19. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension. Lancet 1991;338:1173-4.
20. 1 receptor mechanism. Am J Physiol 1995;267:H2179-85.
21. Adnot S, Raffestin B, Eddamiti S, Braquet P, Chabrie PE. Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J Clin Invest 1991;87:155-62.
22. Frostell CG, Blomqvist H, Hedenstierna G, Lundberg J, Zapol WM. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology 1993;78:427-35.
23. Van Camp JR, Yian C, Lupinetti FM. Regulation of pulmonary vascular resistance by endogenous and exogenous nitric oxide. Ann Thorac Surg 1994;58:1025-30.
24. McIntyre RC Jr, Agrafojo J, Fullerton DA. Pulmonary vascular smooth muscle contraction. J Surg Res 1996;61:170-4.
25. Fratacci M-D, Frostell CG, Chen T-Y, Wain JC, Robinson DR, Zapol WM. Inhaled nitric oxide. A selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. Anesthesiology 1991;75:990-9.
26. Fullerton DA, McIntyre RC Jr, Hahn AR, et al. Dysfunction of cGMP-mediated pulmonary vasorelaxation in endotoxin-induced acute lung injury. Am J Physiol 1995;268 (Lung Cell Mol Physiol):L1029-35.
27. McIntyre RC Jr, Banerjee A, Hahn AR, Agrafojo J, Fullerton DA. Selective inhibition of cAMP mediated pulmonary vasodilation by acute hypoxia. Surgery 1995;117:314-8.
28. Ogura H, Saitoh D, Johnson AA, Mason AD, Pruitt BA, Cioffi WG. The effect of inhaled NO on pulmonary ventilation-perfusion matching following smoke inhalation injury. J Trauma 1994;37:893-8.
29. Ogura H, Cioffi WG, Offner PJ, Jordan BS, Johnson AA, Pruitt BA. Effect of inhaled NO on pulmonary function following sepsis in a swine model. Surgery 1994;116:313-21.
30. Bigatello LM, Huford WE, Kacmarek RM, Roberts JD, Zapol WM. Inhaled nitric oxide is a selective vasodilator in septic patients with severe ARDS. Anesthesiology 1994;80:761-70.
31. Gerlach H, Rossaint R, Pappert D, et al. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 1993;23:499-502.
32. McIntyre RC Jr, Moore FA, Moore EE, Piedalue F, Haenel JS, Fullerton DA. Inhaled nitric oxide variably improves oxygenation and pulmonary hypertension in patients with acute respiratory distress syndrome. J Trauma 1995;39:418-25.
33. Ricou B, Suter PM. Variable effects of nitric oxide in ARDS patients. Am Rev Respir Dis 1993;147:A350.
34. Page Y, Billard JL, Zeni F, et al. Effects of nitric oxide (NO) in ARDS patients seem unpredictable. Crit Care Med 1994;22: A207.
35. Rossaint R, Gerlach H, Schmidt-Ruhnke H, et al. Efficacy of inhaled nitric oxide in patients with severe ARDS. Chest 1995;107:1107-15.
36. Ogura H, Cioffi WG, Jordan BS, et al. The effect of inhaled nitric oxide on smoke inhalation injury in an ovine model. J Trauma 1994;37:294-302.
37. Fierobe L, Brunet F, Dhainaut JF, et al. Effect of inhaled nitric oxide on right ventricular function in adult respiratory distress syndrome. Am J Respir Crit Care Med 1995;151: 1414-19.
38. Wessel DL, Adatia I, Giglia TM, et al. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 1993;88:2128-38.
39. Fullerton DA, Jones SD, Jaggers J, Piedalue F, Grover FL, McIntyre RC Jr. Effective control of pulmonary vascular resistance with inhaled nitric oxide following cardiac operation. J Thorac Cardiovasc Surg (in press).
40. Rich GF, Murphy GD, Roos CM, Johns RA. Inhaled nitric oxide. Selective pulmonary vasodilation in cardiac surgical patients. Anesthesiology 1993;78:1028-35.
41. Rich GF, Lowson SM, Johns RA, Daugherty MO, Uncles DR. Inhaled nitric oxide selectively decreases pulmonary vascular resistance without impairing oxygenation during one-lung ventilation in patients undergoing cardiac surgery. Anesthesiology 1994;80:57-62.
42. Fullerton DA, Mitchel MB, McIntyre RC Jr, et al. Cold ischemia and reperfusion each produce pulmonary vasomotor dysfunction in the transplanted lung. J Thorac Cardiovasc Surg 1993;106:1213-7.
43. Fullerton DA, Mitchel MB, McIntyre RC Jr, Campbell DN, Grover FL. Lung transplantation using cardiopulmonary bypass exaggerates pulmonary vasomotor dysfunction in the transplanted lung. J Thorac Cardiovasc Surg 1995;109:212-7.
44. Badesch DB, Zamora MR, Jones SD, Campbell DN, Fullerton DA. Independent ventilation and extracorporeal membrane oxygenation (ECMO) for severe unilateral pulmonary edema following single lung transplantation for primary pulmonary hypertension. Chest 1995;107:1766-70.
45. Adatia I, Perry S, Landzberg M, Moore P, Thompson JE, Wessel DL. Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantation. J Am Coll Cardiol 1995;25:1656-64.
46. Kierler-Jensen N, Ricksten S-E, Stenqvist O, et al. Inhaled nitric oxide in the evaluation of heart-transplant candidates with elevated pulmonary vascular resistance. J Heart Lung Transplant 1994;13:366-75.
47. Nussbacher A, Sigemituzo A, Kalil R, et al. Mechanism of adenosine-induced elevation of pulmonary capillary wedge pressure in humans. Circulation 1995;92:371-9.
48. Girard C, Durand PG, Vendrinne C, et al. Case 4: 1993 - inhaled nitric oxide for right ventricular failure after heart transplantation. J Cardiothorac Vasc Anesth 1993;7:481-5.
49. Kieler-Jensen N, Lundin S, Ricksten S-E. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside. J Heart Lung Transplant 1995;14:436-43.
50. Fullerton DA, Hahn AR, McIntyre RC Jr. Mechanistic imbalance of pulmonary vasomotor control in progressive lung injury. Surgery 1996;119:98-103.
51. Snell GI, Salamonsen RF, Bergin P, Esmore DS, Khan S, Williams TJ. Inhaled nitric oxide used as a bridge to heart-lung transplantation in a patient with end-stage pulmonary hypertension. Am J Respir Crit Care Med 1995;151:1263-5.
52. Fullerton DA, Mitchel MB, Jones DN, Maki A, McIntyre RC Jr. Pulmonary vasomotor dysfunction is produced with chronically high pulmonary blood flow. J Thorac Cardiovasc Surg 1996;111:190-7.
53. Wessel DL. Inhaled nitric oxide for the treatment of pulmonary hypertension before and after cardiopulmonary by-pass. Crit Care Med 1993;21:S344-5.
54. Robert JD Jr, Lang P, Bigatello LM, Vlahakes GJ, Zapol WM. Inhaled nitric oxide in congenital heart disease. Circulation 1993;87:447-53.
55. Journais D, Pouard P, Mauriat P, Malhère T, Vouhé P, Safran D. Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects. J Thorac Cardiovasc Surg 1994;107:1129-35.
56. Girard C, Lehot J-J, Pannetier JC, Filley S, Ffrench P, Estanove S. Nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension. Anesthesiology 1992;77:880-3.